Sarin Kitpanit

A radiation oncologist | an advanced scuba diver

[Sarin Kitpanit @sarinistic]

Celebrating #RTCU’s impact at #ESTRO #ESTRO2025!
Head & Neck Cancer spotlight:
👃🏻 NPC & olfactory function after RT
⚡️ Proton re-RT for recurrent HNC
Proud of these two brilliant residents from our lab and the heart they put into their work!

[Ben Slotman @bslotman]

Succession planning is key. Very happy that, after leading the #radonc department at @amsterdamumc for almost 30 years, @joostverhoeff has taken over. I have peace of mind and time for other tasks!

[Sarin Kitpanit @sarinistic]

@PeterMacRes @_ShankarSiva @PeterMacCC Congratulations Professor!

[Journal of Neuro-Oncology @JNeurooncol]

Conventional and emerging treatments of astrocytomas and oligodendrogliomas @NSTumorSection #BTSM https://t.co/39qPEwubsi

[Emma B. Holliday MD @DrEmmaHolliday]

Did you know the plural of pancreas is pancreata? 🧐

Here are some pancreata in cookie form to celebrate pancreas week for our #radonc residents @MDAndersonNews. @BenjaminSchrank gave an excellent talk with faculty input from @TaniguchiMD

[RadOnc Tables @RadoncTables]

Some fantastic presentations at ASTRO this year!
On the sheets:

RTOG 1112 HCC
RTOG 1005 SIB breast
MSKCC prophylactic palliation
RTOG 1270/ N107C central review
CURB, LUSTER for NSCLC & breast oligomets
EXTEND prostate oligoprog mets
SCLC dose escalation
LDR v HDR prostate

[The Nobel Prize @NobelPrize]

BREAKING NEWS:
The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”

[The Nobel Prize @NobelPrize]

Marie Curie died of aplastic anaemia on 4 July 1934, a result of years of exposure to radiation through her work. Even today her laboratory notebook from 1899-1902, is radioactive and will be for 1,500 years.

[Shankar Siva @_ShankarSiva]

We are back baby!!!! After a 2-year hiatus the Peter Mac SABR symposium 🇦🇺is being held Nov 18th-19th @PeterMacCC! Stellar all-star faculty, with more TBA; https://t.co/7ZGAeU0gNY

Tickets out soon. Pls register interest on website, and pls RT 🙏🏽 - #sabr2022 #radonc #radiotherapy

[Shalini Vinod @shalinivinod13]

⁦@cd_fuller⁩ presents on predictive model development & validation for prognostic risk stratification in HNC. Great user interface ➡️personalised prediction for #RadOnc to discuss with their patients. How will this be translated into practice? ⁦@ESTRO_RT⁩ #ESTRO2022

[Journal of Clinical Oncology @JCO_ASCO]

‼️ Just published in #JCO: @ASCO rapid guideline update on adjuvant systemic therapy & adjuvant radiation therapy for stage I to IIIA completely resected #NSCLC 🫁 https://t.co/OheQi7Bi97 #lcsm #radonc

[Sarin Kitpanit @sarinistic]

Feeling fantastic to host the morning session of the 17th #THASTRO refresher course for #radonc residents.
Saying hello to the #online attendees from the #onsite team :)

[Drew Moghanaki @DrewMoghanaki]

The Timmerman Files are finally published, along with the confession "In all honesty, except for the spinal cord, all other limits for this original table were my educated guesses". #radonc https://t.co/2eiOG9REkE

[Sarin Kitpanit @sarinistic]

Proudly introduce our latest article "A Systematic Review of Proton Therapy for the Management of Nasopharyngeal Cancer | International Journal of Particle Therapy" on @theijpt special H&N issue. @AnnaLeeMDMPH https://t.co/Zi2yyc4cvj

[Sarin Kitpanit @sarinistic]

Stay tuned!

[IJPT @theijpt]

Preview @SJFrankMD 's introduction to the upcoming IJPT #particletherapy for #headandneck malignancies Special Issue - "the most definitive guide to this new standard of care" is expected online in 2 weeks https://t.co/zPPq5FPAHp #ProtonTherapy

[Dillon Li @dillon_li]

Our new study on nasopharyngeal cancer (NPC): proton therapy with IMPT for localized NPC is associated with fewer acute toxicities compared to standard of care IMRT, with local control rate of 100% at 2 years. @imrtlee @AnnaLeeMDMPH @MSK_RadOnc
https://t.co/YvzYYQyx20

[Michael Breakspear @DrBreaky]

"How to cover letter"; a brief thread from a scientific editor's perspective

Yes, in brief editors do read cover letters although like myself, most pay far less attention than to the abstract and main elements of the paper!

First, a few "do's"

[Jame Abraham, MD, FACP @jamecancerdoc]

https://t.co/nKCZIHYArp @NRGonc 12 new studies opened and 22 in the pipeline: even in the middle of the pandemic @NRGonc investigators are continuing the fight against cancer @NCICancerTrials

[Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) @TiansterZhang]

Great summary for role of adjuvant versus salvage XRT is important for our patients with biochemical recurrent #prostatecancer - @felixfeng with 22-gene classifier from @NRGonc RTOG 9601 trial that may help us define high risk populations needing ADT. @ASCO #GU21